Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple training ease Parents' stress during Child's transplant?

NCT ID NCT07219524

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a problem-solving skills program called Bright IDEAS helps parents of children undergoing stem cell transplants. Thirty-eight parents were randomly assigned to either the training or standard support. The goal was to see if the program is feasible and acceptable, and whether it reduces parents' distress and improves their child's quality of life. Results will show if this approach is worth testing in larger trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bright IDEAS Problem-Solving Skills Training (behavioral intervention)
What this could lead to
If it works, this could give parents practical tools to cope better during their child's transplant, possibly reducing stress and improving family well-being.
What could go wrong
This is a small feasibility study with only 38 participants, so results may not apply to all families. The training requires time and effort, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

Nov 2020

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Children Inclusion Criteria: * Male and females of any race or ethnicity, ages 0 to 21 years * Allogeneic or autologous HSCT planned with reduced intensity or myeloablative conditioning Exclusion Criteria: * Concurrent enrollment on a research study testing psychoeducational interventions for parents and/or patients Parent Inclusion Criteria: * One parent or primary caregiver per child * Able to speak, read, and write English or Spanish, and give informed consent Exclusion Criteria: * Child or adolescent refusal to participate * Parent age less than 18 years.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stem cell transplantation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital Los Angeles

    Los Angeles, California, 90027, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.